Despite Shrinking by US$96m in the Past Week, Amneal Pharmaceuticals (NASDAQ:AMRX) Shareholders Are Still up 128% Over 1 Year

Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really flourishing, you can make more than 100%. Take, for example Amneal Pharmaceuticals, I

Simply Wall StJun 19 07:33 ET

Conart Engineers Bags Work Order Worth INR31 Million

Conart Engineers (BOM:522231) has received a work order worth 31.0 million Indian rupees from Amneal Pharmaceuticals, according to a Monday filing to the stock BSE. The contract is for the constructio

MT NewswiresJun 17 03:48 ET

USA faces the most severe drug shortage in a decade, with low stock price drugs and weight loss drugs becoming "disaster zones".

Last year, the USA experienced the most serious drug shortage crisis in a decade.

Zhitong FinanceJun 16 23:35 ET

U.S. Drug Shortages Worsen to Reach a Decade High: Report

Seeking AlphaJun 15 11:19 ET

Teva Asthma Inhaler Patents Are 'Improperly Listed' in FDA Orange Book

Seeking AlphaJun 12 12:51 ET

Reported Monday June 10, 2024 "Amneal, U.S. FTC Win Order Removing Teva Inhaler Patents From FDA List" - Reuters News

Drugmaker Amneal Pharmaceuticals (AMRX.O), opens new tab with the backing of the U.S. Federal Trade Commission convinced a New Jersey federal court on Monday to remove five Teva Pharmaceutical (TEVA.T

BenzingaJun 11 10:40 ET